FORT WORTH, Texas—Alakananda Basu, Ph.D. is now Associate Director for Basic Research for the Institute for Cancer Research at the University of North Texas Health Science Center. She will be working closely with Ronald Goldfarb, Ph.D., Institute for Cancer Research director, and Kenneth Brunson, Ph.D., deputy director, in formulating basic research and translational research strategies. In this capacity, she will help foster the research priorities of more than 60 institute members.
Dr. Basu joined the health science center from the University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute. She now serves as an associate professor in the molecular biology and immunology department and as an executive member of the institute at the health science center.
She has served on many national cancer review study sections and is internationally known for her cancer research in experimental therapeutics, tumor cell signal transduction, apoptosis and drug resistance.
The Institute for Cancer Research was established in January 1999 to study how cancer spreads in the human body. The Institute contributes to new approaches for cancer prevention, diagnosis and treatment.
If you are with the media and need additional information or would like to arrange an interview,
please contact Jeff Carlton, Director of Media Relations, at 817-735-7630.